Desirability-Based Methods of Multiobjective Optimization and Ranking for Global QSAR Studies. Filtering Safe and Potent Drug Candidates from Combinatorial Libraries

Abstract

Up to now, very few applications of multiobjective optimization (MOOP) techniques to quantitative structure-activity relationship (QSAR) studies have been reported in the literature. However, none of them report the optimization of objectives related directly to the final pharmaceutical profile of a drug. In this paper, a MOOP method based on Derringer's desirability function that allows conducting global QSAR studies, simultaneously considering the potency, bioavailability, and safety of a set of drug candidates, is introduced. The results of the desirability-based MOOP (the levels of the predictor variables concurrently producing the best possible compromise between the properties determining an optimal drug candidate) are used for the implementation of a ranking method that is also based on the application of desirability functions. This method allows ranking drug candidates with unknown pharmaceutical properties from combinatorial libraries according to the degree of similarity with the previously determined optimal candidate. Application of this method will make it possible to filter the most promising drug candidates of a library (the best-ranked candidates), which should have the best pharmaceutical profile (the best compromise between potency, safety and bioavailability). In addition, a validation method of the ranking process, as well as a quantitative measure of the quality of a ranking, the ranking quality index (Psi), is proposed. The usefulness of the desirability-based methods of MOOP and ranking is demonstrated by its application to a library of 95 fluoroquinolones, reporting their gram-negative antibacterial activity and mammalian cell cytotoxicity. Finally, the combined use of the desirability-based methods of MOOP and ranking proposed here seems to be a valuable tool for rational drug discovery and development.

From flamingo dance to (desirable) drug discovery: a nature-inspired approach

“…Finally, comparison of the classification and VS performances showed that, despite better classification performance being achieved for the dual A 2A AR/MAO-B ligands, a better VS performance was obtained for the antimalarial data set. This finding supports our previous observation that good classification performances do not ensure good VS results [35]. Thus, the evaluation of the models in VS conditions using proper data sets is an essential component of any cheminformatics effort for VS.…”

Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species

“…4,5 This kind of study may also help in a multi objective optimization (MOOP) of desired properties or activity of drugs against different targets; see for instance the recent works carried out by Cruz-Monteagudo in the topic. 6,7 In principle, up-to-date there are over 1600 molecular descriptors that may be generalized and used to solve the former problem. 8,9 Many of these indices are known as topological indices (TIs) or simply invariants of a molecular graph, whose vertices are atoms weighed with physicochemical properties (mass, polarity, electro negativity, or charge).…”

Ecotoxicological Modeling, Ranking and Prioritization of Pharmaceuticals Using QSTR and i‐QSTTR Approaches: Application of 2D and Fragment Based Descriptors

“…Considering the number of data points considered in modeling, diverse nature of the training compounds and model statistics, the derived models are considered to be sufficiently robust to make precise predictions for new data points. However, we may also note that multi‐criteria virtual screening aspects as reported previously may also perform well in such situations …”